Related Experiment Video
Updated: Aug 17, 2026

Bimolecular Fluorescence Complementation
Published on: April 15, 2011
Biological evaluation of 2-fluoro-2-[123I]iodo-mannose (FIM): biological evaluation of FIM
Abstract:
This paper describes the biodistribution of a radio-iodinated analog of fluorodeoxyglucose (FDG). 123I-2-fluoro-2-iodo-mannose (FIM) was investigated as a potential single photon emission tomography (SPECT) imaging agent. We also compare the results with the observed distribution of the classical PET agent 18F-FDG and newly developed 18F-difluorodeoxyglucose (DFDG). Following radioiodination, the final product was stable in-vitro for 24 hrs. Mice showed a rapid blood clearance and deiodination of the 123I-FIM reflected by high stomach and thyroid uptake. Comparison with 18F-FDG and 18F-DFDG revealed a large discrepancy between the 18F labeled sugars and the 123I-FIM biological distribution. The iodinated product was not found to be a metabolic marker for in-vivo studies.
Insights
123I-2-fluoro-2-iodo-mannose (FIM) showed rapid blood clearance and deiodination in mice, unlike 18F-FDG and 18F-DFDG. This radioiodinated mannose analog is not a suitable metabolic marker for in-vivo SPECT imaging.
Area of Science:
- Nuclear medicine
- Radiochemistry
- Biomedical imaging
Background:
- Fluorodeoxyglucose (FDG) is a widely used PET imaging agent.
- Development of novel radiotracers for SPECT imaging is crucial for broader clinical application.
- 123I-labeled compounds offer advantages for SPECT due to their favorable gamma emission properties.
Purpose of the Study:
- To evaluate 123I-2-fluoro-2-iodo-mannose (FIM) as a potential SPECT imaging agent.
- To compare the biodistribution of 123I-FIM with established PET agents 18F-FDG and 18F-DFDG.
- To determine if 123I-FIM can serve as a metabolic marker in vivo.
Main Methods:
- Radioiodination of 2-fluoro-2-iodo-mannose to produce 123I-FIM.
- In vitro stability assessment of 123I-FIM.
- Biodistribution studies of 123I-FIM in mice.
- Comparison of biodistribution data with published data for 18F-FDG and 18F-DFDG.
Main Results:
- 123I-FIM demonstrated in vitro stability for 24 hours.
- Mice exhibited rapid blood clearance and significant deiodination of 123I-FIM.
- High uptake was observed in the stomach and thyroid, indicating deiodination.
- Biodistribution of 123I-FIM significantly differed from that of 18F-FDG and 18F-DFDG.
- 123I-FIM did not function as a metabolic marker in vivo.
Conclusions:
- 123I-FIM is unstable in vivo, undergoing rapid deiodination.
- The biodistribution pattern of 123I-FIM is not comparable to 18F-FDG or 18F-DFDG.
- 123I-FIM is not a suitable radiotracer for in vivo metabolic imaging via SPECT.
More Related Videos
09:44Oral Biofilm Analysis of Palatal Expanders by Fluorescence In-Situ Hybridization and Confocal Laser Scanning Microscopy
Published on: October 20, 2011
09:38FSL Constructs: A Simple Method for Modifying Cell/Virion Surfaces with a Range of Biological Markers Without Affecting their Viability
Published on: August 5, 2011